New York, NY (January 23, 2012) The Damon Runyon Cancer Research Foundation announced that five scientists with novel approaches to fighting cancer have been named 2012 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists ...

(Massachusetts Eye and Ear Infirmary) Research to Prevent Blindness has awarded Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, a $30,000 Medical Student Eye Research Fellowship. The award will support the work of Mamta Shah.

(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation announced that five scientists with novel approaches to fighting cancer have been named 2012 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects ...

Boston (Jan. 23, 2012) Research to Prevent Blindness (RPB) has awarded Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, a $30,000 Medical Student Eye Research Fellowship. The award will support the work of Ms. Mamta Shah. The award will allow Ms. Shah ...

The University of Washington Medical Center was recently granted Magnet Recognition Program status from the American Nurses Credentialing Center (ANCC) for its excellence in nursing practice and patient care. This is the fifth consecutive time that UWMC has achieved this status, making it the only hospital in the country to ...

(University of Washington - Health Sciences/UW News, Community Relations & Marketing) The University of Washington Medical Center was recently granted Magnet Recognition Program status from the American Nurses Credentialing Center for its excellence in nursing practice and patient care. This is the fifth consecutive time that UWMC has achieved this ...

The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.

Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and ...

Adamis Pharmaceuticals Corporation (OTCBB: ADMP.OB), today announced the technology which constitutes its compound APC-100 was recently granted a patent in the United States. A patent entitled "Chroman-Derived Compounds for the Treatment of Cancer" has been issued. This patent, together with earlier issued European and US patents, significantly strengthens the Adamis ...

Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug ("IND") meeting with the U.S. Food and Drug Administration ("FDA") on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis ...

ELISA Technologies, Inc., announced that its EZ Gluten® Test Kit has earned Performance-Tested MethodsSM (PTM) certification from the AOAC Research Institute (AOAC RI). EZ Gluten® was developed to help food industry and consumers detect gluten in food and beverages. The EZ Gluten® Test Kit delivers highly accurate results in about ...